Potential Breakthrough For T-Cell Lymphoma Patients With Drug That Mimics Folic Acid
Friday, December 12, 2008 - 21:21
in Health & Medicine
Preliminary results of a pivotal Phase 2 clinical trial of pralatrexate, a drug that partially works by mimicking folic acid, showed a complete or partial response in 27 percent of patients with recurrent or resistant peripheral T-cell lymphoma.